Download presentation
Presentation is loading. Please wait.
Published byRoy Summers Modified over 8 years ago
1
Transjugular Intrahepatic Portosystemic Shunt (TIPS) R4 박철기
2
Introduction A non-surgical method of portal decompression. Creation of a low resistant channel through liver parenchyme using stent between hepatic vein and intrahepatic portal vein. Side to side porto-caval shunt
3
Procedure Channel between Rt hepatic vein and Rt intrahepatic portal vein. www.irtreatment.com
4
Procedure Hemodynamic Goal 50% decrease of pre-TIPS portal pressure www.irtreatment.com
5
Indications Careful patient selection due to no improvement of survival & greater incidence of hepatic encephalopathy
6
Complication
7
Procedural Complications Laceration of vessel Arrhythmia Hemobilia Arterioportal fistula Hepatic infarction Hemoperitoneum Sepsis
8
TIPS dysfunction & stent related complication Thrombosis : early event in 10~15% of Pts. leakage of bile into shunt possible cause of PTE early reestablishment & LMWH Stenosis : pseudointimal hyperplasia Stent migration & kinking
9
Tips dysfunction & stent related complication Hemolytic anemia : mechanical stress to red cells Hb ↓, Reticulocyte ↑, Haptoglobin ↓, autoimmune marker (-) Jaundice : not from worsening of patient’s liver disease resolve within 4 weeks of TIPS placement
10
Porto-systemic encephalopathy (PSE) PSE : Shunting of ammonia & other neurotoxines in portal circulation. major drawback of TIPS Risk factors : old age (>65yrs) poor liver function (Child C) prior HE high diameter stent (>10mm) low porto-systemic pressure gradient after TIPS (5mmHG)
11
Hemodynamic change & associated complication Hepatic circulatory change Portal flow diversion from terminal venule to main portal vein sinusoidal perfusion depend on hepatic arterial flow but if hepatic artery cannot provide adequate sinusoidal perfusion progressive liver failure
12
Hemodynamic change & associated complication Extrahepatic circulatory change Increased venous return Increased cardiac output Normal effective arterial volume Decreased RAA system Dramatic Shift of blood to IVC
13
Hemodynamic change & associated complication Extrahepatic circulatory change Cardiac output ↑ + systemic vasodilation Exaggeration of hyperdynamic circulatory state Induce heart failure
14
Contraindication Chronic recurrent hepatic encephalopathy Severe liver failure (Child score > 11) Heart failure Severe pulmonary hypertension Liver abscess Old age (>65yrs) Pre-TIPS evaluation : Exact hepatic function evaluation (Child class & MELD score), EKG, Echocardiography, Chest X-ray, Infection control.
15
Some possible causes of hyperbilirubinemia after TIPS Hemolysis Progressive hepatic failure Biliary-venous fistula
16
Some possible causes of hyperbilirubinemia after TIPS Hemolysis Cause : Direct RBC trauma from stent Clinical manifestation : Jaundice, dyspnea, DOE Lab finding : Hb ↓, Reticulocytosis, Hyperbilirubinemia(indirect>direct), Haptoglobin ↓, Autoimmune hemolytic marker (-) Diagnosis : Lab & clinical finding Tx : usually resolve within 3~4 weeks after TIPS
17
Some possible causes of hyperbilirubinemia after TIPS Progressive hepatic failure Cause : Hepatic sinosoidal hypoperfusion Clinical manifestation : Encephalopathy (confusion, disorientation, coma) Lab finding : Hyperbilirubinemia, PT prolongation AST/ALT ↑ Diagnosis : Lab & clinical finding Tx : Liver transplantation
18
Some possible causes of hyperbilirubinemia after TIPS Biliary-venous fistula Cause : Procedural sequelae Clinical manifestation : jaundice, recurrent fever, shock Hemobilia, anemia Lab finding : Hyperbilirubinemia, Leukocytosis, ESR/CRP ↑ Recurrent positive blood culture (mainly G(-)) Diagnosis : ERCP (direct visualization of contrast run-off) Tx : broad-spectrum antibiotics embolization of fistula. spontaneous closure by biliary decompression(stenting)
19
HemolysisProgressive hepatic failure Biliary-venous fistula CauseRBC traumaHepatic hypoperfusionProcedural sequelae Clinical manifestationJaundice Dyspnea/DOE Encephalopathy (confusion, coma) Jaundice, recurrent fever, shock Lab findingHb ↓ Reticulocytosis Hyperbilirubinemia (indirect>direct) Haptoglobin ↓ Autoimmune hemolytic marker (-) Hyperbilirubinemia PT prolongation AST/ALT ↑ Hyperbilirubinemia Leukocytosis ESR/CRP ↑ Recurrent positive blood culture (mainly G(-)) DiagnosisLab & clinical finding ERCP (direct visualizat ion of contrast run-off) Therapyresolve within 3~4 wks after TIPS LTbroad-spectrum antibio tics embolization of fistula. spontaneous closure by biliary decompressi on(stenting)
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.